Eric Rowinsky will not seek re-election to Fortress Biotech board at 2024 annual meeting

Fortress Biotech, Inc.

Dr. Rowinsky to step down as director at the 2024 annual meeting due to other professional commitments.
He will continue to serve as a consultant to the Company after his Board departure.
No disagreement with the Company's operations, policies, or practices.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Eric Rowinsky

Director

FBIO · Fortress Biotech, Inc.

Filed: January 26, 2024, 6:59 PM ET

Eric Rowinsky, M.D., a director currently serving on the board of directors of Fortress Biotech, Inc. (the “ Company ”), informed the Company that he does not intend to stand for re-election at the Company’s 2024 annual meeting of stockholders (the “ 2024 Annual Meeting ”) due to other professional commitments.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Eric Rowinsky departed as Director at Fortress Biotech, Inc..

Action: not seeking re-election
Role: Director

Exact text from the filing

Eric Rowinsky, M.D., a director currently serving on the board of directors of Fortress Biotech, Inc. (the “ Company ”), informed the Company that he does not intend to stand for re-election at the Company’s 2024 annual meeting of stockholders (the “ 2024 Annual Meeting ”) due to other professional commitments.

View on SEC.gov

Fortress Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-007245

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.